Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer's disease

被引:116
|
作者
Hijazi, Sara [1 ]
Heistek, Tim S. [2 ]
Scheltens, Philip [3 ,4 ]
Neumann, Ulf [5 ]
Shimshek, Derya R. [5 ]
Mansvelder, Huibert D. [2 ]
Smit, August B. [1 ]
van Kesteren, Ronald E. [1 ]
机构
[1] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam Neurosci, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam Neurosci, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Alzheimer Ctr, Amsterdam Neurosci, Med Ctr, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Dept Neurol, Amsterdam Neurosci, Med Ctr, Amsterdam, Netherlands
[5] Novartis Inst BioMed Res, Neurosci Res, Basel, Switzerland
关键词
HIPPOCAMPAL GABAERGIC NEURONS; AMYLOID-BETA; POSITIVE INTERNEURONS; EPILEPTIFORM ACTIVITY; GAMMA-OSCILLATIONS; DYSFUNCTION; INHIBITION; SEIZURES; DEFICITS; CELLS;
D O I
10.1038/s41380-019-0483-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuronal network dysfunction is increasingly recognized as an early symptom in Alzheimer's disease (AD) and may provide new entry points for diagnosis and intervention. Here, we show that amyloid-beta-induced hyperexcitability of hippocampal inhibitory parvalbumin (PV) interneurons importantly contributes to neuronal network dysfunction and memory impairment in APP/PS1 mice, a mouse model of increased amyloidosis. We demonstrate that hippocampal PV interneurons become hyperexcitable at ~16 weeks of age, when no changes are observed yet in the intrinsic properties of pyramidal cells. This hyperexcitable state of PV interneurons coincides with increased inhibitory transmission onto hippocampal pyramidal neurons and deficits in spatial learning and memory. We show that treatment aimed at preventing PV interneurons from becoming hyperexcitable is sufficient to restore PV interneuron properties to wild-type levels, reduce inhibitory input onto pyramidal cells, and rescue memory deficits in APP/PS1 mice. Importantly, we demonstrate that early intervention aimed at restoring PV interneuron activity has long-term beneficial effects on memory and hippocampal network activity, and reduces amyloid plaque deposition, a hallmark of AD pathology. Taken together, these findings suggest that early treatment of PV interneuron hyperactivity might be clinically relevant in preventing memory decline and delaying AD progression.
引用
收藏
页码:3380 / 3398
页数:19
相关论文
共 50 条
  • [1] Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer’s disease
    Sara Hijazi
    Tim S. Heistek
    Philip Scheltens
    Ulf Neumann
    Derya R. Shimshek
    Huibert D. Mansvelder
    August B. Smit
    Ronald E. van Kesteren
    [J]. Molecular Psychiatry, 2020, 25 : 3380 - 3398
  • [2] Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer?s disease
    Kater, Mandy S. J.
    Huffels, Christiaan F. M.
    Oshima, Takuya
    Renckens, Niek S.
    Middeldorp, Jinte
    Boddeke, Erik W. G. M.
    Smit, August B.
    Eggen, Bart J. L.
    Hol, Elly M.
    Verheijen, Mark H. G.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2023, 107 : 225 - 241
  • [3] Modelling the contributions to hyperexcitability in a mouse model of Alzheimer's disease
    Mittag, Martin
    Mediavilla, Laura
    Remy, Stefan
    Cuntz, Hermann
    Jedlicka, Peter
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2023, 601 (15): : 3403 - 3437
  • [4] Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
    Morgan, D
    Diamond, DM
    Gottschall, PE
    Ugen, KE
    Dickey, C
    Hardy, J
    Duff, K
    Jantzen, P
    DiCarlo, G
    Wilcock, D
    Connor, K
    Hatcher, J
    Hope, C
    Gordon, M
    Arendash, GW
    [J]. NATURE, 2000, 408 (6815) : 982 - 985
  • [5] Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
    Dave Morgan
    David M. Diamond
    Paul E. Gottschall
    Kenneth E. Ugen
    Chad Dickey
    John Hardy
    Karen Duff
    Paul Jantzen
    Giovanni DiCarlo
    Donna Wilcock
    Karen Connor
    Jaime Hatcher
    Caroline Hope
    Marcia Gordon
    Gary W. Arendash
    [J]. Nature, 2000, 408 : 982 - 985
  • [6] 7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer's Disease
    Zhang, Zhentao
    Liu, Xia
    Schroeder, Jason P.
    Chan, Chi-Bun
    Song, Mingke
    Yu, Shan Ping
    Weinshenker, David
    Ye, Keqiang
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 (03) : 638 - 650
  • [7] 7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer’s Disease
    Zhentao Zhang
    Xia Liu
    Jason P Schroeder
    Chi-Bun Chan
    Mingke Song
    Shan Ping Yu
    David Weinshenker
    Keqiang Ye
    [J]. Neuropsychopharmacology, 2014, 39 : 638 - 650
  • [8] Reversible memory loss in a mouse transgenic model of Alzheimer's disease
    Kotilinek, LA
    Bacskai, B
    Westerman, M
    Kawarabayashi, T
    Younkin, L
    Hyman, BT
    Younkin, S
    Ashe, KH
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (15): : 6331 - 6335
  • [9] The Mitochondria-Targeted Antioxidant MitoQ Prevents Loss of Spatial Memory Retention and Early Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease
    McManus, Meagan J.
    Murphy, Michael P.
    Franklin, James L.
    [J]. JOURNAL OF NEUROSCIENCE, 2011, 31 (44): : 15703 - 15715
  • [10] Involvement of GABAergic interneuron dysfunction and neuronal network hyperexcitability in Alzheimer's disease: Amelioration by metabolic switching
    Mattson, Mark P.
    [J]. METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 191 - 205